The
different arms of the trial were very well - matched as regards age (average age ≈ 55 y, ± 5 - 7 y depending on subgroup), education, time from onset of disease, and MDS - UPDRS scores at onset; the only
evident differences were a higher number of males and higher
body weight
in the low - dose treatment group.